
Title:
Dexamethasone
Text:
Corticosteroid medication



.mw-parser-output .infobox-subbox{padding:0;border:none;margin:-3px;width:auto;min-width:100%;font-size:100%;clear:none;float:none;background-color:transparent}.mw-parser-output .infobox-3cols-child{margin:auto}.mw-parser-output .infobox .navbar{font-size:100%}body.skin-minerva .mw-parser-output .infobox-header,body.skin-minerva .mw-parser-output .infobox-subheader,body.skin-minerva .mw-parser-output .infobox-above,body.skin-minerva .mw-parser-output .infobox-title,body.skin-minerva .mw-parser-output .infobox-image,body.skin-minerva .mw-parser-output .infobox-full-data,body.skin-minerva .mw-parser-output .infobox-below{text-align:center}DexamethasoneClinical dataTrade namesDextenza, Ozurdex, Cortidex, Neofordex, othersAHFS/Drugs.comMonographMedlinePlusa682792License data
EU EMA: by INN
US DailyMed: Dexamethasone
Pregnancycategory
AU: A (oral); C (parenteral)[1]

Routes ofadministrationBy mouth, intravenous therapy (IV), intramuscular injection (IM), subcutaneous injection (SC), intraosseous (IO), eye dropATC codeA01AC02 (WHO) C05AA09 (WHO), D07AB19 (WHO), D10AA03 (WHO), H02AB02 (WHO), R01AD03 (WHO), S01BA01 (WHO), S02BA06 (WHO), S03BA01 (WHO)Legal statusLegal status
AU: S4 (Prescription only) 
CA:  ℞-only 
UK: POM (Prescription only) 
US: ℞-only 
EU: Rx-only [2][3]
In general: ℞ (Prescription only)
Pharmacokinetic dataBioavailability80–90%Protein binding77%MetabolismLiverElimination half-lifebiological half-life: 36 to 54 hours; plasma half-life: 4 to 5 hours[4][5]ExcretionUrine (65%)Identifiers
IUPAC name
(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one
CAS Number50-02-2 YPubChem CID5743IUPHAR/BPS2768DrugBankDB01234 NChemSpider5541 YUNII7S5I7G3JQLKEGGD00292 YChEBICHEBI:41879 YChEMBLChEMBL384467 YPDB ligandDEX (PDBe, RCSB PDB)CompTox Dashboard (EPA)DTXSID3020384 ECHA InfoCard100.000.004 Chemical and physical dataFormulaC22H29FO5Molar mass392.467 g·mol−13D model (JSmol)Interactive imageMelting point262 °C (504 °F)
SMILES
O=C(CO)[C@]3(O)[C@]2(C[C@H](O)[C@]4(F)[C@@]1(C(=CC(=O)C=C1)CC[C@H]4[C@@H]2C[C@H]3C)C)C

InChI
InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1 YKey:UREBDLICKHMUKA-CXSFZGCWSA-N Y
.mw-parser-output .nobold{font-weight:normal} NY (what is this?)  (verify)
Dexamethasone is a glucocorticoid medication[6] used to treat rheumatic problems, a number of skin diseases, severe allergies, asthma, chronic obstructive lung disease, croup, brain swelling, eye pain following eye surgery, superior vena cava syndrome (a complication of some forms of cancer),[7] and along with antibiotics in tuberculosis.[6] In adrenocortical insufficiency, it may be used in combination with a mineralocorticoid medication such as fludrocortisone.[6] In preterm labor, it may be used to improve outcomes in the baby.[6] It may be given by mouth, as an injection into a muscle, as an injection into a vein, as a topical cream or ointment for the skin or as a topical ophthalmic solution to the eye.[6] The effects of dexamethasone are frequently seen within a day and last for about three days.[6]
The long-term use of dexamethasone may result in thrush, bone loss, cataracts, easy bruising, or muscle weakness.[6] It is in pregnancy category C in the United States, meaning that it should only be used when the benefits are predicted to be greater than the risks.[1] In Australia, the oral use is category A, meaning it has been frequently used in pregnancy and not been found to cause problems to the baby.[8] It should not be taken when breastfeeding.[6] Dexamethasone has anti-inflammatory and immunosuppressant effects.[6]
Dexamethasone was first synthesized in 1957 by Philip Showalter Hench and was approved for medical use in 1961.[9][10][11] 
It is on the World Health Organization's List of Essential Medicines.[12] In 2019, it was the 359th most commonly prescribed medication in the United States, with fewer than one million prescriptions.[13]

Contents

1 Medical uses

1.1 Anti-inflammatory
1.2 Cancer
1.3 COVID‑19
1.4 Endocrine
1.5 Pregnancy
1.6 High-altitude illnesses
1.7 Nausea and vomiting
1.8 Sore throat


2 Contraindications
3 Adverse effects

3.1 Common
3.2 Unknown frequency
3.3 Withdrawal


4 Interactions
5 Pharmacology
6 Chemistry

6.1 Synthesis


7 History
8 Society and culture

8.1 Price
8.2 Nonmedical use


9 Veterinary use
10 See also
11 References
12 External links



Medical uses[edit]
  Dexamethasone phosphate injection ampoules
Anti-inflammatory[edit]
Dexamethasone is used to treat many inflammatory and autoimmune disorders, such as rheumatoid arthritis and bronchospasm.[14] Idiopathic thrombocytopenic purpura, a decrease in numbers of platelets due to an immune problem, responds to 40 mg daily for four days; it may be administered in 14-day cycles. It is unclear whether dexamethasone in this condition is significantly better than other glucocorticoids.[15]
It is also given in small amounts[16] before and/or after some forms of dental surgery, such as the extraction of the wisdom teeth, an operation which often causes puffy, swollen cheeks.[medical citation needed]
Dexamethasone is commonly given as a treatment for croup in children, as a single dose can reduce the swelling of the airway to improve breathing and reduce discomfort.[17]
It is injected into the heel when treating plantar fasciitis, sometimes in conjunction with triamcinolone acetonide.[medical citation needed]
It is useful to counteract allergic anaphylactic shock, if given in high doses.[medical citation needed]
It is present in certain eye drops – particularly after eye surgery – and as a nasal spray, and certain ear drops (can be combined with an antibiotic and an antifungal). Dexamethasone intravitreal steroid implants have been approved by the FDA  to treat ocular conditions such as diabetic macular edema, central retinal vein occlusion, and uveitis.[18] Dexamethasone has also been used with antibiotics to treat acute endophthalmitis.[19]
Dexamethasone is used in transvenous screw-in cardiac pacing leads to minimize the inflammatory response of the myocardium. The steroid is released into the myocardium as soon as the screw is extended and can play a significant role in minimizing the acute pacing threshold due to the reduction of inflammatory response. The typical quantity present in a lead tip is less than 1.0 mg.[medical citation needed]
Dexamethasone may be administered before antibiotics in cases of bacterial meningitis. It acts to reduce the inflammatory response of the body to the bacteria killed by the antibiotics (bacterial death releases proinflammatory mediators that can cause a response which is harmful), thus reducing hearing loss and neurological damage.[20]

  A single ampoule of dexamethasone phosphate for injection
Cancer[edit]
People with cancer undergoing chemotherapy are often given dexamethasone to counteract certain side effects of their antitumor treatments. Dexamethasone can increase the antiemetic effect of 5-HT3 receptor antagonists, such as ondansetron.[21] The exact mechanism of this interaction is not well-defined, but it has been theorized that this effect may be due to, among many other causes, inhibition of prostaglandin synthesis, anti-inflammatory effects, immunosuppressive effects, decreased release of endogenous opioids, or a combination of the aforementioned.[22]
In brain tumors (primary or metastatic), dexamethasone is used to counteract the development of edema, which could eventually compress other brain structures. It is also given in cord compression, where a tumor is compressing the spinal cord.[medical citation needed] Evidence on the safety and efficacy of using dexamethasone to treat malignant brain tumors is not clear.[23]
Dexamethasone is also used as a direct chemotherapeutic agent in certain hematological malignancies, especially in the treatment of multiple myeloma, in which dexamethasone is given alone or in combination with other chemotherapeutic drugs, including most commonly with thalidomide (Thal-dex), lenalidomide, bortezomib (Velcade, Vel-dex),[24] or a combination of doxorubicin (Adriamycin) and vincristine or bortezomib/lenalidomide/dexamethasone.[medical citation needed]

COVID‑19[edit]


.mw-parser-output .hatnote{font-style:italic}.mw-parser-output div.hatnote{padding-left:1.6em;margin-bottom:0.5em}.mw-parser-output .hatnote i{font-style:normal}.mw-parser-output .hatnote+link+.hatnote{margin-top:-0.5em}See also: COVID-19 drug repurposing research § Dexamethasone
Dexamethasone is recommended by the National Health Service in the UK and the National Institutes of Health (NIH) in the US for patients with COVID-19 who need either mechanical ventilation or supplemental oxygen (without ventilation).[25][26]
The Infectious Diseases Society of America (IDSA) guideline panel suggests the use of glucocorticoids for patients with severe COVID-19, defined as patients with SpO2 ≤94% on room air, and those who require supplemental oxygen, mechanical ventilation, or extracorporeal membrane oxygenation (ECMO).[27] The IDSA recommends against the use of glucocorticoids for those with COVID‑19 without hypoxemia requiring supplemental oxygen.[27]
The World Health Organization (WHO) recommends systemic corticosteroids rather than no systemic corticosteroids for the treatment of people with COVID-19 (strong recommendation, based on moderate certainty evidence).[28] The WHO suggests not to use corticosteroids in the treatment of people with non-severe COVID-19 (conditional recommendation, based on low certainty evidence).[28]
The Oxford University RECOVERY Trial issued a press release announcing preliminary results that the drug could reduce deaths by about a third in participants on ventilators and by about a fifth in participants on oxygen; it did not benefit patients who did not require respiratory support.[29] A meta-analysis of seven clinical trials of critically ill COVID-19 patients, each treated with one of three different corticosteroids found a statistically significant reduction in death.[30] The largest reduction was obtained with dexamethasone (36% compared to placebo).[30][31]
In September 2020, the European Medicines Agency (EMA) endorsed the use of dexamethasone in adults and adolescents (from twelve years of age and weighing at least 40 kg) who require supplemental oxygen therapy.[32] Dexamethasone can be taken by mouth or given as an injection or infusion (drip) into a vein.[32]
The mechanism of action of dexamethasone involves suppression of late-stage interferon type I programs in severe COVID-19 patients.[33]

Endocrine[edit]
Dexamethasone is the treatment for the very rare disorder of glucocorticoid resistance.[34][35]
In adrenal insufficiency and Addison's disease, dexamethasone is prescribed when the patient does not respond well to prednisone or methylprednisolone.[medical citation needed]
It can be used in congenital adrenal hyperplasia in older adolescents and adults to suppress ACTH production. It is typically given at night.[36]

Pregnancy[edit]
Dexamethasone may be given to women at risk of delivering prematurely to promote maturation of the fetus' lungs. This administration, given from one day to one week before delivery, has been associated with low birth weight, although not with increased rates of neonatal death.[37]
Dexamethasone has also been used during pregnancy as an off-label prenatal treatment for the symptoms of congenital adrenal hyperplasia (CAH) in female babies. CAH causes a variety of physical abnormalities, notably ambiguous genitalia. Early prenatal CAH treatment has been shown to reduce some CAH symptoms, but it does not treat the underlying congenital disorder. This use is controversial: it is inadequately studied, only around one in ten of the fetuses of women treated are at risk of the condition, and serious adverse events have been documented.[38] Experimental use of dexamethasone in pregnancy for fetal CAH treatment was discontinued in Sweden when one in five cases suffered adverse events.[39]
A small clinical trial found long-term effects on verbal working memory among the small group of children treated prenatally, but the small number of test subjects means the study cannot be considered definitive.[40][41]

High-altitude illnesses[edit]
Dexamethasone is used in the treatment of high-altitude cerebral edema (HACE), as well as high-altitude pulmonary edema (HAPE).[42] It is commonly carried on mountain-climbing expeditions to help climbers deal with complications of altitude sickness.[43][44]

Nausea and vomiting[edit]
Intravenous dexamethasone is effective for prevention of nausea and vomiting in people who had surgery and whose post-operative pain was treated with long-acting spinal or epidural spinal opioids.[45]
The combination of dexamethasone and a 5-HT3 receptor antagonist such as ondansetron is more effective than a 5-HT3 receptor antagonist alone in preventing postoperative nausea and vomiting.[46]

Sore throat[edit]
A single dose of dexamethasone or another steroid speeds improvement of a sore throat.[47]

Contraindications[edit]
Contraindications of dexamethasone include,[48][49] but are not limited to:

Uncontrolled infections
Known hypersensitivity to dexamethasone
Cerebral malaria
Systemic fungal infection
Concurrent treatment with live virus vaccines (including smallpox vaccine)
Adverse effects[edit]
The exact incidence of the adverse effects of dexamethasone are not available, hence estimates have been made as to the incidence of the adverse effects below based on the adverse effects of related corticosteroids and on available documentation on dexamethasone.[49][50][51][52][53]

Common[edit]
.mw-parser-output .div-col{margin-top:0.3em;column-width:30em}.mw-parser-output .div-col-small{font-size:90%}.mw-parser-output .div-col-rules{column-rule:1px solid #aaa}.mw-parser-output .div-col dl,.mw-parser-output .div-col ol,.mw-parser-output .div-col ul{margin-top:0}.mw-parser-output .div-col li,.mw-parser-output .div-col dd{page-break-inside:avoid;break-inside:avoid-column}
Acne
Amnesia
Birth defect
Cataract (in cases of long-term treatment, it occurs in about 10% of patients)
Confusion
Depression
Dyspepsia
Euphoria
Headaches
Hiccups (in cases of long-term treatment, it occurs in about 11% of patients)
Hyperglycemia
Hypertension
Impaired skin healing and wound repair
Increased appetite
Increased risk of viral, bacterial, fungal, and parasitic infections
Insomnia
Irritability
Malaise
Muscle atrophy and myopathy
Nausea
Ocular hypertension
Osteoporosis
Vertigo
Vomiting
Weight gain

Unknown frequency[edit]

Abdominal distension
Adrenal suppression
Allergic reactions (including anaphylaxis)
Arterial thrombosis
Aspergillosis
Bruising
Candidiasis
Cardiomyopathy
Cleft palate
Corneal or scleral thinning
Cushing's syndrome
Edema
Esophageal ulcer
Facial plethora
Glaucoma
Growth stunting (in children)
Herpes zoster
Hypernatremia
Hypertriglyceridemia
Hypocalcemia
Hypokalemia
Intracranial hypertension (long-term treatment)
Leukocytosis
Mania
Mucormycosis
Pancreatitis (inflammation of the pancreas)
Papilledema
Peptic ulcer
Protein catabolism (causing nitrogen depletion)
Psychological dependence
Psychosis
Seizures
Skin atrophy
Striae
Telangiectasia
Thromboembolism
Venous thrombosis
Vertebral collapse

Withdrawal[edit]
Sudden withdrawal after long-term treatment with corticosteroids can lead to:[49]


Adrenal insufficiency
Arthralgia
Conjunctivitis
Death
Fever
Hypotension
Myalgia
Nodule (medicine) (painful, itchy skin condition)
Rhinitis
Weight loss

Interactions[edit]
Known drug interactions include:[49]

Inducers of hepatic microsomal enzymes such as barbiturates, phenytoin, and rifampicin can reduce the half-life of dexamethasone.[medical citation needed]
Cotreatment with oral contraceptives can increase its volume of distribution.[medical citation needed]
Pharmacology[edit]
As a glucocorticoid, dexamethasone is an agonist of the glucocorticoid receptor (GR). It has minimal mineralocorticoid activity.[54][55][56]

Chemistry[edit]
Dexamethasone is a synthetic pregnane corticosteroid and derivative of cortisol (hydrocortisone) and is also known as 1-dehydro-9α-fluoro-16α-methylhydrocortisone or as 9α-fluoro-11β,17α,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione.[57][58] The molecular and crystal structure of dexamethasone has been determined by X-ray crystallography.[59] It is a stereoisomer of betamethasone, the two compounds differing only in the spatial configuration of the methyl group at position 16 (see steroid nomenclature).[60]

Synthesis[edit]
To synthesize dexamethasone, 16β-methylprednisolone acetate is dehydrated to the 9,11-dehydro derivative.[61][62] This is then reacted with a source of hypobromite, such as basic N-bromosuccinimide, to form the 9α-bromo-11β-hydrin derivative, which is then ring-closed to an epoxide. A ring-opening reaction with hydrogen fluoride in tetrahydrofuran gives dexamethasone.[citation needed]

  Dexamethasone synthesis
History[edit]
Dexamethasone was first synthesized by Philip Showalter Hench in 1957.[9][10] It was introduced for medical use in 1958.[55]
On 16 June 2020, the RECOVERY Trial announced preliminary results stating that dexamethasone improves survival rates of hospitalized patients with COVID‑19 receiving oxygen or on a ventilator. Benefits were only observed in patients requiring respiratory support; those who did not require breathing support saw a worse survival rate than the control group, although the difference may have been due to chance.[63]
A preprint containing the full dataset was published on 22 June 2020 and demand for dexamethasone surged after publication of the preprint.[64] The preliminary report was published in The New England Journal of Medicine on 18 July 2020.[65]
The World Health Organization (WHO) states that dexamethasone should be reserved for seriously ill and critical patients receiving COVID‑19 treatment in a hospital setting,[66] and the WHO Director-General stated that "WHO emphasizes that dexamethasone should only be used for patients with severe or critical disease, under close clinical supervision. There is no evidence this drug works for patients with mild disease or as a preventative measure, and it could cause harm."[67] In July 2020, the WHO stated they are in the process of updating treatment guidelines to include dexamethasone or other steroids.[68] In September 2020, the WHO released updated guidance on using corticosteroids for COVID‑19.[28]
In July 2020, the European Medicines Agency (EMA) started reviewing results from the RECOVERY study arm that involved the use of dexamethasone in the treatment of patients with COVID‑19 admitted to the hospital to provide an opinion on the results and in particular the potential use of dexamethasone for the treatment of adults with COVID-19.[69][70] In September 2020, the EMA received an application for marketing authorization of dexamethasone for COVID‑19.[71]

Society and culture[edit]
Price[edit]
Dexamethasone is inexpensive.[72] In the United States a month of medication is typically priced less than US$25.[6] In India, a course of treatment for preterm labor is about US$0.50.[72] The drug is available in most areas of the world.[72]

Nonmedical use[edit]
Dexamethasone is given in legal Bangladesh brothels to prostitutes not yet of legal age, causing weight gain aimed at making them appear older and healthier to customers and police.[73]
Dexamethasone and most glucocorticoids are banned by sporting bodies including the World Anti-Doping Agency.[74]

Veterinary use[edit]
Combined with marbofloxacin and clotrimazole, dexamethasone is available under the name Aurizon, CAS number 115550-35-1, and used to treat difficult ear infections, especially in dogs. It can also be combined with trichlormethiazide to treat horses with swelling of distal limbs and general bruising.[75]

See also[edit]
Dexamethasone suppression test
References[edit]
.mw-parser-output .reflist{font-size:90%;margin-bottom:0.5em;list-style-type:decimal}.mw-parser-output .reflist .references{font-size:100%;margin-bottom:0;list-style-type:inherit}.mw-parser-output .reflist-columns-2{column-width:30em}.mw-parser-output .reflist-columns-3{column-width:25em}.mw-parser-output .reflist-columns{margin-top:0.3em}.mw-parser-output .reflist-columns ol{margin-top:0}.mw-parser-output .reflist-columns li{page-break-inside:avoid;break-inside:avoid-column}.mw-parser-output .reflist-upper-alpha{list-style-type:upper-alpha}.mw-parser-output .reflist-upper-roman{list-style-type:upper-roman}.mw-parser-output .reflist-lower-alpha{list-style-type:lower-alpha}.mw-parser-output .reflist-lower-greek{list-style-type:lower-greek}.mw-parser-output .reflist-lower-roman{list-style-type:lower-roman}

^ Jump up to: a b .mw-parser-output cite.citation{font-style:inherit;word-wrap:break-word}.mw-parser-output .citation q{quotes:"\"""\"""'""'"}.mw-parser-output .citation:target{background-color:rgba(0,127,255,0.133)}.mw-parser-output .id-lock-free a,.mw-parser-output .citation .cs1-lock-free a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/6/65/Lock-green.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-limited a,.mw-parser-output .id-lock-registration a,.mw-parser-output .citation .cs1-lock-limited a,.mw-parser-output .citation .cs1-lock-registration a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/d/d6/Lock-gray-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .id-lock-subscription a,.mw-parser-output .citation .cs1-lock-subscription a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/a/aa/Lock-red-alt-2.svg")right 0.1em center/9px no-repeat}.mw-parser-output .cs1-ws-icon a{background:linear-gradient(transparent,transparent),url("//upload.wikimedia.org/wikipedia/commons/4/4c/Wikisource-logo.svg")right 0.1em center/12px no-repeat}.mw-parser-output .cs1-code{color:inherit;background:inherit;border:none;padding:inherit}.mw-parser-output .cs1-hidden-error{display:none;color:#d33}.mw-parser-output .cs1-visible-error{color:#d33}.mw-parser-output .cs1-maint{display:none;color:#3a3;margin-left:0.3em}.mw-parser-output .cs1-format{font-size:95%}.mw-parser-output .cs1-kern-left{padding-left:0.2em}.mw-parser-output .cs1-kern-right{padding-right:0.2em}.mw-parser-output .citation .mw-selflink{font-weight:inherit}"Dexamethasone Use During Pregnancy". Drugs.com. Archived from the original on 17 May 2016. Retrieved 9 June 2016. Dexamethasone is only recommended for use during pregnancy when there are no alternatives and benefit outweighs risk.

^ "Ozurdex EPAR". European Medicines Agency (EMA). Retrieved 24 October 2020.

^ "Neofordex EPAR". European Medicines Agency (EMA). Retrieved 24 October 2020.

^ Dogra P, Vijayashankar NP (14 September 2020). "Dexamethasone Suppression Test". StatPearls (September 14, 2020). PMID 31194457.

^ Jobe AH, Milad MA, Peppard T, Jusko WJ (March 2020). "Pharmacokinetics and Pharmacodynamics of Intramuscular and Oral Betamethasone and Dexamethasone in Reproductive Age Women in India". Clinical and Translational Science. 13 (2): 391–99. doi:10.1111/cts.12724. PMC 7070803. PMID 31808984.

^ Jump up to: a b c d e f g h i j "Dexamethasone". The American Society of Health-System Pharmacists. Archived from the original on 31 August 2017. Retrieved 29 July 2015.

^ Wilkinson, Ian B. (13 July 2017). Oxford Handbook of Clinical Medicine. OUP Oxford. p. 176. ISBN 9780199689903.

^ "Prescribing medicines in pregnancy database". Australian Government. 3 March 2014. Archived from the original on 8 April 2014. Retrieved 22 April 2014. Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.

^ Jump up to: a b "Dexamethasone". 17 June 2020.

^ Jump up to: a b Rankovic Z, Hargreaves R, Bingham M (2012). Drug discovery and medicinal chemistry for psychiatric disorders. Cambridge: Royal Society of Chemistry. p. 286. ISBN 9781849733656. Archived from the original on 5 March 2016.

^ Fischer J, Ganellin CR (2006). Analogue-based Drug Discovery. John Wiley & Sons. p. 485. ISBN 9783527607495.

^ World Health Organization (2019). World Health Organization model list of essential medicines: 21st list 2019. Geneva: World Health Organization. hdl:10665/325771. WHO/MVP/EMP/IAU/2019.06.

^ "Dexamethasone – Drug Usage Statistics". ClinCalc. Retrieved 16 October 2021.

^ Till J. "Paramedic Clinical Training Aid". Archived from the original on 31 March 2012. Retrieved 30 August 2011.

^ Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB,  et al. (January 2010). "International consensus report on the investigation and management of primary immune thrombocytopenia". Blood. 115 (2): 168–86. doi:10.1182/blood-2009-06-225565. PMID 19846889.

^ Schmelzeisen R, Frölich JC (1993). "Prevention of postoperative swelling and pain by dexamethasone after operative removal of impacted third molar teeth". European Journal of Clinical Pharmacology. 44 (3): 275–77. doi:10.1007/BF00271371. PMID 8491244. S2CID 12528750.

^ "Croup – Diagnosis & Treatment". Mayo Clinic. Retrieved 13 October 2017. Dexamethasone is usually recommended because of its long-lasting effects (up to 72 hours).

^ Brady CJ, Villanti AC, Law HA, Rahimy E, Reddy R, Sieving PC,  et al. (February 2016). "Corticosteroid implants for chronic non-infectious uveitis". Cochrane Database of Systematic Reviews. 2: CD010469. doi:10.1002/14651858.CD010469.pub2. PMC 5038923. PMID 26866343.

^ Kim CH, Chen MF, Coleman AL (February 2017). "Adjunctive steroid therapy versus antibiotics alone for acute endophthalmitis after intraocular procedure". Cochrane Database of Systematic Reviews. 2: CD012131. doi:10.1002/14651858.CD012131.pub2. PMC 5419424. PMID 28225198.

^ Brouwer MC, McIntyre P, Prasad K, van de Beek D (September 2015). "Corticosteroids for acute bacterial meningitis". Cochrane Database of Systematic Reviews (9): CD004405. doi:10.1002/14651858.CD004405.pub5. PMC 6491272. PMID 26362566.

^ Roila F, Ballatori E, Ruggeri B, DeAngelis V (May 2000). "Dexamethasone alone or in combination with ondansetron for the prevention of delayed nausea and vomiting induced by chemotherapy". The New England Journal of Medicine. 342 (21): 1554–59. doi:10.1056/NEJM200005253422102. PMID 10824073.

^ Holte K, Kehlet H (November 2002). "Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications". Journal of the American College of Surgeons. 195 (5): 694–712. doi:10.1016/s1072-7515(02)01491-6. PMID 12437261.

^ Jessurun CA, Hulsbergen AF, Cho LD, Aglio LS, Nandoe Tewarie RD, Broekman ML (September 2019). "Evidence-based dexamethasone dosing in malignant brain tumors: what do we really know?". J Neurooncol. 144 (2): 249–264. doi:10.1007/s11060-019-03238-4. PMC 6700052. PMID 31346902.

^ Harousseau JL, Attal M, Leleu X, Troncy J, Pegourie B, Stoppa AM,  et al. (November 2006). "Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study". Haematologica. 91 (11): 1498–505. PMID 17043025. 

^ "Dexamethasone and COVID-19". SPS – Specialist Pharmacy Service. Archived from the original on 22 July 2020. Retrieved 22 July 2020.

^ "Corticosteroids". COVID-19 Treatment Guidelines. National Institutes of Health. Retrieved 12 July 2020.

^ Jump up to: a b "COVID-19 Guideline, Part 1: Treatment and Management". Infectious Diseases Society of America. Retrieved 22 July 2020. Recommendation 4. Among hospitalized patients with severe* COVID-19, the IDSA guideline panel suggests glucocorticoids rather than no glucocorticoids. (Conditional recommendation, Moderate certainty of evidence)Remark: Dexamethasone 6 mg IV or PO for 10 days (or until discharge if earlier) or equivalent glucocorticoid dose may be substituted if dexamethasone unavailable. Equivalent total daily doses of alternative glucocorticoids to dexamethasone 6 mg daily are methylprednisolone 32 mg and prednisone 40 mg.Recommendation 5. Among hospitalized patients with COVID-19 without hypoxemia requiring supplemental oxygen, the IDSA guideline panel suggests against the use of glucocorticoids. (Conditional recommendation, Low certainty of evidence)

^ Jump up to: a b c World Health Organization (2020). Corticosteroids for COVID-19: living guidance, 2 September 2020 (Report). World Health Organization. hdl:10665/334125. WHO/2019-nCoV/Corticosteroids/2020.1. Lay summary. {{cite report}}: Cite uses deprecated parameter |lay-url= (help)

^ "Dexamethasone reduces death in hospitalised patients with severe respiratory complications of COVID-19". University of Oxford. 16 June 2020. Retrieved 16 June 2020.

^ Jump up to: a b Sterne JA, Murthy S, Diaz JV, Slutsky AS, Villar J, Angus DC,  et al. (The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group) (September 2020). "Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19: A Meta-analysis". JAMA. 324 (13): 1330–1341. doi:10.1001/jama.2020.17023. PMC 7489434. PMID 32876694. S2CID 221467783.

^ Prescott HC, Rice TW (September 2020). "Corticosteroids in COVID-19 ARDS: Evidence and Hope During the Pandemic". JAMA. 324 (13): 1292–1295. doi:10.1001/jama.2020.16747. PMID 32876693. S2CID 221468015.

^ Jump up to: a b "EMA endorses use of dexamethasone in COVID-19 patients on oxygen or mechanical ventilation". European Medicines Agency (EMA) (Press release). 18 September 2020. Retrieved 21 September 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

^ Sinha, Sarthak; Rosin, Nicole L.; Arora, Rohit; Labit, Elodie; Jaffer, Arzina; Cao, Leslie; Farias, Raquel; Nguyen, Angela P.; de Almeida, Luiz G. N.; Dufour, Antoine; Bromley, Amy (15 November 2021). "Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19". Nature Medicine: 1–11. doi:10.1038/s41591-021-01576-3. ISSN 1546-170X. PMID 34782790. S2CID 244132637.

^ Chrousos GP, Detera-Wadleigh SD, Karl M (December 1993). "Syndromes of glucocorticoid resistance" (PDF). Annals of Internal Medicine. 119 (11): 1113–24. doi:10.7326/0003-4819-119-11-199312010-00009. PMID 8239231. S2CID 26040431. Archived from the original (PDF) on 14 August 2017. Retrieved 4 July 2020.

^ Charmandari E, Kino T, Ichijo T, Chrousos GP (May 2008). "Generalized glucocorticoid resistance: clinical aspects, molecular mechanisms, and implications of a rare genetic disorder". The Journal of Clinical Endocrinology and Metabolism. 93 (5): 1563–72. doi:10.1210/jc.2008-0040. PMC 2386273. PMID 18319312.

^ Dan L. Longo, Anthony Fauci, Dennis Kasper, Stephen Hauser, J. Jerry Jameson and Joseph Loscalzo, Harrison's Principles of Internal Medicine, 18th edition, p. 3055

^ Bloom SL, Sheffield JS, McIntire DD, Leveno KJ (April 2001). "Antenatal dexamethasone and decreased birth weight". Obstetrics and Gynecology. 97 (4): 485–90. doi:10.1016/S0029-7844(00)01206-0. PMID 11275014. S2CID 33601749.

^ Elton C (18 June 2010). "A Prenatal Treatment Raises Questions of Medical Ethics". Archived from the original on 31 August 2016 – via content.time.com.

^ Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S (June 2012). "Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint". The Journal of Clinical Endocrinology and Metabolism. 97 (6): 1881–83. doi:10.1210/jc.2012-1222. PMID 22466333.

^ Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S (February 2007). "Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone". The Journal of Clinical Endocrinology and Metabolism. 92 (2): 542–48. doi:10.1210/jc.2006-1340. PMID 17148562.

^ Lajic S, Nordenström A, Hirvikoski T (2011). "Long-term outcome of prenatal dexamethasone treatment of 21-hydroxylase deficiency". Endocrine Development. 20: 96–105. doi:10.1159/000321228. ISBN 978-3-8055-9643-5. PMID 21164263.

^ Simancas-Racines D, Arevalo-Rodriguez I, Osorio D, Franco JV, Xu Y, Hidalgo R (June 2018). "Interventions for treating acute high altitude illness". Cochrane Database Syst Rev. 6 (12): CD009567. doi:10.1002/14651858.CD009567.pub2. PMC 6513207. PMID 29959871.

^ Cymerman A, Rock PB (1994). "Medical Problems in High Mountain Environments. A Handbook for Medical Officers" (PDF). USARIEM-TN94-2. US Army Research Inst. of Environmental Medicine Thermal and Mountain Medicine Division Technical Report. Archived from the original (PDF) on 17 June 2017. Retrieved 17 June 2020. {{cite journal}}: Cite journal requires |journal= (help)

^ Eledrisi MS (April 2007). "First-line therapy for hypertension". Annals of Internal Medicine. 146 (8): 615. doi:10.7326/0003-4819-146-8-200704170-00021. PMID 17438328.

^ Grape S, Usmanova I, Kirkham KR, Albrecht E (April 2018). "Intravenous dexamethasone for prophylaxis of postoperative nausea and vomiting after administration of long-acting neuraxial opioids: a systematic review and meta-analysis". Anaesthesia. 73 (4): 480–89. doi:10.1111/anae.14166. PMID 29226971.

^ Kovac AL (May 2006). "Meta-analysis of the use of rescue antiemetics following PONV prophylactic failure with 5-HT3 antagonist/dexamethasone versus single-agent therapies". The Annals of Pharmacotherapy. 40 (5): 873–87. doi:10.1345/aph.1G338. PMID 16670361. S2CID 32843029.

^ Sadeghirad B, Siemieniuk RA, Brignardello-Petersen R, Papola D, Lytvyn L, Vandvik PO,  et al. (September 2017). "Corticosteroids for treatment of sore throat: systematic review and meta-analysis of randomised trials". BMJ. 358: j3887. doi:10.1136/bmj.j3887. PMC 5605780. PMID 28931508.

^ "Decadron, Dexamethasone Intensol (dexamethasone) dosing, indications, interactions, adverse effects, and more". Medscape Reference. WebMD. Archived from the original on 12 December 2013. Retrieved 11 December 2013.

^ Jump up to: a b c d "Product Information Dexamethsone (dexamethasone)" (PDF). TGA eBusiness Services. Aspen Pharmacare Australia Pty Ltd. 10 August 2010. Retrieved 11 December 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)

^ "Product Information Dexmethsone Injection" (PDF). TGA eBusiness ServicesAspen Pharmacare Australia Pty Ltd. Aspen Pharmacare Australia Pty Ltd. 2 March 2011. Retrieved 11 December 2013. (Accept terms and conditions to open PDF, which doesn't work in archived version)

^ "Dexamethasone tablet [ECR Pharmaceuticals]". DailyMed. ECR Pharmaceuticals. December 2010. Archived from the original on 13 December 2013. Retrieved 11 December 2013.

^ "Dexamethasone Tablet BP 2.0 mg – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 26 January 2018. Retrieved 17 June 2020.

^ "Dexamethasone 4.0 mg/ml injection – Summary of Product Characteristics (SPC)". electronic Medicines Compendium. Merck Sharp & Dohme Limited. 4 December 2013. Archived from the original on 8 May 2015. Retrieved 11 December 2013.

^ De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R, New M, Purnell J, Rebar R, Singer F, Vinik A, Nicolaides NC, Pavlaki AN, Maria Alexandra MA, Chrousos GP (2000). "Glucocorticoid Therapy and Adrenal Suppression". MDText.com. PMID 25905379. {{cite journal}}: Cite journal requires |journal= (help)

^ Jump up to: a b Khan MO, Park KK, Lee HJ (2005). "Antedrugs: an approach to safer drugs". Current Medicinal Chemistry. 12 (19): 2227–39. doi:10.2174/0929867054864840. PMID 16178782.

^ Liu D, Ahmet A, Ward L, Krishnamoorthy P, Mandelcorn ED, Leigh R, Brown JP, Cohen A, Kim H (August 2013). "A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy". Allergy, Asthma, and Clinical Immunology. 9 (1): 30. doi:10.1186/1710-1492-9-30. PMC 3765115. PMID 23947590.

^ Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. pp. 366–. ISBN 978-1-4757-2085-3. Archived from the original on 15 February 2017.

^ Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. pp. 310–. ISBN 978-3-88763-075-1. Archived from the original on 24 August 2017.

^ Raynor JW, Minor W, Chruszcz M (2007). "Dexamethasone at 119 K". Acta Crystallographica Section E. 63 (6): o2791–93. doi:10.1107/S1600536807020806.

^ Antignac JP, Le Bizec B, Monteau F, Andre F (January 2002). "Differentiation of betamethasone and dexamethasone using liquid chromatography/positive electrospray tandem mass spectrometry and multivariate statistical analysis". Journal of Mass Spectrometry. 37 (1): 69–75. Bibcode:2002JMSp...37...69A. doi:10.1002/jms.260. PMID 11813313.

^ Arth GE, Fried J, Johnston DBR, Hoff DR, Sarett HL, Silber RH, Stoerk HC, Winter CA (1958). "16-Methylated steroids. II. 16α-Methyl analogs of cortisone, a new group of anti-inflammatory steroids. 9α-Halo derivatives". Journal of the American Chemical Society. 80 (12): 3161–63. doi:10.1021/ja01545a063.

^ Taub D, Hoffsommer RD, Slates HL, lWendler NL (1958). "16β-Methyl cortical steroids". Journal of the American Chemical Society. 80 (16): 4435. doi:10.1021/ja01549a095.

^ "Dexamethasone in COVID-19" (PDF). www.gpni.co.uk. 16 June 2020. Retrieved 18 June 2020.

^ Mahase E (June 2020). "Covid-19: Demand for dexamethasone surges as RECOVERY trial publishes preprint". BMJ. 369: m2512. doi:10.1136/bmj.m2512. PMID 32576548.

^ Horby P, Lim WS, Emberson JR, Mafham M, Bell JL, Linsell L,  et al. (July 2020). "Dexamethasone in Hospitalized Patients with Covid-19 – Preliminary Report". New England Journal of Medicine. 384 (8): 693–704. doi:10.1056/NEJMoa2021436. PMC 7383595. PMID 32678530.

^ "Important to use dexamethasone only for serious COVID cases – WHO". 17 June 2020. Retrieved 18 June 2020.

^ "WHO Director-General's opening remarks at the media briefing on COVID-19". World Health Organization. 22 June 2020. Retrieved 26 June 2020.

^ "Q&A: Dexamethasone and COVID-19". World Health Organization (WHO). Retrieved 12 July 2020.

^ "EMA starts review of dexamethasone for treating adults with COVID-19 requiring respiratory support". European Medicines Agency (EMA) (Press release). 24 July 2020. Retrieved 27 July 2020. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.

^ "EMA to review results from study testing common steroid drug against COVID-19". Reuters. 24 July 2020. Retrieved 27 July 2020.

^ "EMA receives application for marketing authorisation of Dexamethasone Taw COVID-19". European Medicines Agency (EMA). 2 September 2020. Retrieved 2 September 2020.

^ Jump up to: a b c "Dexamethasone for Accelerating Lung Maturation in Preterm Babies" (PDF). Archived (PDF) from the original on 22 December 2015. Retrieved 29 July 2015.

^ Dummett M (30 May 2010). "Bangladesh's dark brothel steroid secret". BBC News Online. Archived from the original on 22 February 2012.

^ "Prohibited In-Competition: Glucocorticoids". World Anti-Doping Agency.

^ "Trichlormethiazide and Dexamethasone for veterinary use". Wedgewood Pharmacy. Archived from the original on 12 December 2007. Retrieved 23 January 2008.


External links[edit]



Wikimedia Commons has media related to Dexamethasone.

"Dexamethasone". Drug Information Portal. U.S. National Library of Medicine.
"Dexamethasone Ophthalmic". MedlinePlus.
"Dexamethasone Injection". MedlinePlus.
.mw-parser-output .navbox{box-sizing:border-box;border:1px solid #a2a9b1;width:100%;clear:both;font-size:88%;text-align:center;padding:1px;margin:1em auto 0}.mw-parser-output .navbox .navbox{margin-top:0}.mw-parser-output .navbox+.navbox,.mw-parser-output .navbox+.navbox-styles+.navbox{margin-top:-1px}.mw-parser-output .navbox-inner,.mw-parser-output .navbox-subgroup{width:100%}.mw-parser-output .navbox-group,.mw-parser-output .navbox-title,.mw-parser-output .navbox-abovebelow{padding:0.25em 1em;line-height:1.5em;text-align:center}.mw-parser-output .navbox-group{white-space:nowrap;text-align:right}.mw-parser-output .navbox,.mw-parser-output .navbox-subgroup{background-color:#fdfdfd}.mw-parser-output .navbox-list{line-height:1.5em;border-color:#fdfdfd}.mw-parser-output .navbox-list-with-group{text-align:left;border-left-width:2px;border-left-style:solid}.mw-parser-output tr+tr>.navbox-abovebelow,.mw-parser-output tr+tr>.navbox-group,.mw-parser-output tr+tr>.navbox-image,.mw-parser-output tr+tr>.navbox-list{border-top:2px solid #fdfdfd}.mw-parser-output .navbox-title{background-color:#ccf}.mw-parser-output .navbox-abovebelow,.mw-parser-output .navbox-group,.mw-parser-output .navbox-subgroup .navbox-title{background-color:#ddf}.mw-parser-output .navbox-subgroup .navbox-group,.mw-parser-output .navbox-subgroup .navbox-abovebelow{background-color:#e6e6ff}.mw-parser-output .navbox-even{background-color:#f7f7f7}.mw-parser-output .navbox-odd{background-color:transparent}.mw-parser-output .navbox .hlist td dl,.mw-parser-output .navbox .hlist td ol,.mw-parser-output .navbox .hlist td ul,.mw-parser-output .navbox td.hlist dl,.mw-parser-output .navbox td.hlist ol,.mw-parser-output .navbox td.hlist ul{padding:0.125em 0}.mw-parser-output .navbox .navbar{display:block;font-size:100%}.mw-parser-output .navbox-title .navbar{float:left;text-align:left;margin-right:0.5em}Medical uses
.mw-parser-output .navbar{display:inline;font-size:88%;font-weight:normal}.mw-parser-output .navbar-collapse{float:left;text-align:left}.mw-parser-output .navbar-boxtext{word-spacing:0}.mw-parser-output .navbar ul{display:inline-block;white-space:nowrap;line-height:inherit}.mw-parser-output .navbar-brackets::before{margin-right:-0.125em;content:"[ "}.mw-parser-output .navbar-brackets::after{margin-left:-0.125em;content:" ]"}.mw-parser-output .navbar li{word-spacing:-0.125em}.mw-parser-output .navbar a>span,.mw-parser-output .navbar a>abbr{text-decoration:inherit}.mw-parser-output .navbar-mini abbr{font-variant:small-caps;border-bottom:none;text-decoration:none;cursor:inherit}.mw-parser-output .navbar-ct-full{font-size:114%;margin:0 7em}.mw-parser-output .navbar-ct-mini{font-size:114%;margin:0 4em}vteGlucocorticoids and antiglucocorticoids (D07, H02)GlucocorticoidsNatural
Cortisone
Cortisone acetate
Cortodoxone (cortexolone, 11-deoxycortisol)
Desoxycortone (deoxycortone, cortexone, 11-deoxycorticosterone)
Desoxycortone esters
Hydrocortisone (cortisol)#
Hydrocortisone esters
Prebediolone acetate
Pregnenolone
Pregnenolone acetate
Pregnenolone succinate
Synthetic
Cortisol-like and related (16-unsubstituted): Chloroprednisone
Cloprednol
Difluprednate
Fludrocortisone
Flugestone acetate (flurogestone acetate)
Fluocinolone
Fluorometholone
Fluorometholone acetate
Fluperolone
Fluperolone acetate
Fluprednisolone
Fluprednisolone esters
Loteprednol
Medrysone
Methylprednisolone
Methylprednisolone esters
Prednicarbate
Prednisolone#
Prednisone
Tixocortol
Tixocortol pivalate
Methasones and related (16-substituted): Alclometasone
Beclometasone
Beclometasone esters
Betamethasone#
Betamethasone esters
Clobetasol
Clobetasol propionate
Clobetasone
Clocortolone
Clocortolone esters
Cortivazol
Desoximetasone
Dexamethasone#
Dexamethasone esters
Diflorasone
Diflucortolone
Diflucortolone valerate
Fluclorolone
Flumetasone
Fluocortin
Fluocortolone
Fluocortolone esters
Fluprednidene acetate
Fluticasone
Fluticasone furoate
Fluticasone propionate
Halometasone
Meprednisone
Mometasone
Mometasone furoate
Paramethasone
Prednylidene
Rimexolone
Triamcinolone
Ulobetasol (halobetasol)
Cyclic ketals (16,17-cyclized): Amcinonide
Budesonide
Ciclesonide
Deflazacort
Desonide
Fluclorolone acetonide (flucloronide)
Fludroxycortide (flurandrenolone, flurandrenolide)
Flunisolide
Fluocinolone acetonide
Fluocinonide
Formocortal (fluoroformylone)
Halcinonide
Triamcinolone acetonide
Triamcinolone acetonide esters
Antiglucocorticoids
Antagonists: Aglepristone
Ketoconazole
Mifepristone
Ulipristal acetate
Synthesis modifiers
Acetoxolone
Aminoglutethimide
Carbenoxolone
Enoxolone
Ketoconazole
Metyrapone
Mitotane
Trilostane

#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III

See also
Glucocorticoid receptor modulators
Mineralocorticoids and antimineralocorticoids
List of corticosteroids
vteDecongestants and other nasal preparations (R01)TopicalSympathomimetics, plain
Cyclopentamine
Ephedrine
Epinephrine
Fenoxazoline
Levomethamphetamine
Metizoline
Naphazoline
Oxymetazoline
Phenylephrine
Propylhexedrine
Tetryzoline
Tramazoline
Tuaminoheptane
Tymazoline
Xylometazoline
Antiallergic agents,excluding corticosteroids
Spaglumic acid
histamine antagonists (Levocabastine
Antazoline
Thonzylamine)
mast cell stabilizer (some are also antihistamines) (Cromoglicic acid
Nedocromil
Azelastine
Olopatadine
Lodoxamide)
Corticosteroids
Beclometasone dipropionate
Betamethasone#
Budesonide
Ciclesonide
Dexamethasone
Flunisolide
Fluticasone (Fluticasone furoate, Fluticasone propionate)
Mometasone furoate
Prednisolone#
Tixocortol
Triamcinolone
Triamcinolone acetonide
Other nasal preparations
Cafaminol
Calcium hexamine thiocyanate
Eucalyptus oil
Framycetin
Hexamidine
Hyaluronan
Ipratropium bromide
Mupirocin
Retinol
Ritiometan
Saline water
Combination products
Olopatadine/mometasone
Systemic use:Sympathomimetics
Ephedrine
Phenylephrine
Phenylpropanolamine
Pseudoephedrine (+azatadine, +dexbrompheniramine, +loratadine)

#WHO-EM
‡Withdrawn from market
Clinical trials:
†Phase III
§Never to phase III

vteAppetite stimulants (A15)Exogenous
Amitriptyline
Clonidine
Cyproheptadine
Dexamethasone
Dronabinol/Tetrahydrocannabinol (Cannabis)
Medroxyprogesterone acetate
Megestrol acetate
Mirtazapine
Nabilone
Nandrolone
Olanzapine
Omega-3 fatty acid
Oxandrolone
Pentoxifylline
Prednisone
Sugars
Testosterone
Thalidomide
Endogenous
ACTH/Corticotropin
Adiponectin
Agouti-related peptide
Anandamide
Cortisol/Hydrocortisone
Cortisone
Ghrelin
Melanin-concentrating hormone
Melatonin
Neuropeptide Y
Orexin/Hypocretin

vteDrugs used for diseases of the ear (S02)Infection
Acetic acid
Aluminium acetotartrate
Aluminium triacetate (Burow's solution)
Boric acid
Chloramphenicol
Chlorhexidine
Ciprofloxacin
Clioquinol
Gentamicin
Hydrogen peroxide
Miconazole
Neomycin
Nitrofurazone
Ofloxacin
Polymyxin B
Rifamycin
Tetracycline
Corticosteroids
Betamethasone
Dexamethasone
Fluocinolone acetonide
Hydrocortisone
Prednisolone
Analgesics and anesthetics
Lidocaine
Cocaine
Phenazone

vteStomatological preparations (A01)Caries prophylaxis
Dectaflur
Olaflur
Sodium fluoride
Sodium monofluorophosphate
Stannous fluoride
Infection and antiseptics
Amphotericin B
Benzoxonium chloride
Chlorhexidine
Chlortetracycline
Clotrimazole
Cetylpyridinium chloride
Domiphen bromide
Doxycycline
Eugenol
Hexetidine
Hydrogen peroxide
Mepartricin
Metronidazole
Miconazole
Minocycline
Natamycin
Neomycin
Oxyquinoline
Polynoxylin
Sodium perborate
Tetracycline
Tibezonium iodide
Corticosteroids (Glucocorticoids)
Dexamethasone
Hydrocortisone
Triamcinolone
Other
Amlexanox
Acetylsalicylic acid
Becaplermin
Benzydamine
Epinephrine/Adrenalone

vteVasoprotectives (C05)Antihemorrhoidals for topical usecorticosteroids
Hydrocortisone
Prednisolone
Betamethasone
Fluorometholone
Fluocortolone
Dexamethasone
Fluocinolone acetonide
Fluocinonide
local anesthetics
Lidocaine
Tetracaine
Benzocaine
Dibucaine
Procaine
Oxetacaine
Pramocaine
other
Tribenoside
Antivaricose therapyheparins or heparinoids for topical use
Organo-heparinoid
Sodium apolate
Heparin
Pentosan polysulfate
sclerosing agents for local injection
Monoethanolamine oleate
Polidocanol
Inverted sugar syrup
Sodium tetradecyl sulfate
Phenol
other
Calcium dobesilate
Capillary stabilising agentsbioflavonoids
Rutoside
Monoxerutin
Diosmin
Troxerutin
Hidrosmin
other
Tribenoside
Etamsylate

Pharmacodynamics
vteGlucocorticoid receptor modulatorsGRAgonists
Cortisol-like and related (16-unsubstituted): 3α,5α-Tetrahydrocorticosterone
5α-Dihydrocorticosterone
9α-Fluorocortisone (alfluorone)
11-Dehydrocorticosterone (11-oxocorticosterone, 17-deoxycortisone)
11-Dehydrocorticosterone acetate
11-Deoxycorticosterone (desoxycortone, deoxycortone, desoxycorticosterone)
Desoxycortone esters
11-Deoxycortisol (cortodoxone, cortexolone)
Cortifen (cortiphen, kortifen)
Cortodoxone acetate
21-Deoxycortisol
Δ7-Prednisolone
Δ7-Prednisolone 21-acetate
Amebucort
Chloroprednisone
Chloroprednisone acetate
Cloprednol
Cloprednol acetate
Corticosterone
Corticosterone acetate
Corticosterone benzoate
Cortisol (hydrocortisone)
Benzodrocortisone (hydrocortisone benzoate)
Hydrocortamate (hydrocortisone diethylaminoacetate)
Hydrocortisone esters
Cortisone
Cortisone acetate
Deprodone
Deprodone propionate
Dichlorisone
Dichlorisone acetate
Dichlorisone diacetate
Difluprednate
Endrisone (endrysone)
Etiprednol
Etiprednol dicloacetate (etiprednol dichloroacetate)
Fludrocortisone (fludrocortone)
Fludrocortisone acetate
Fluorometholone
Fluorometholone acetate
Fluperolone
Fluperolone acetate
Fluprednisolone
Fluprednisolone esters
Halopredone
Halopredone acetate (halopredone diacetate)
Isoflupredone (9α-fluoroprednisolone)
Isoflupredone acetate
Loteprednol
Mazipredone (depersolone)
Medrysone
Methylprednisolone
Methylprednisolone esters
Prebediolone
Prebediolone acetate
Prednisolone
Prednazate
Prednazoline
Prednicarbate (prednisolone ethylcarbonate propionate)
Prednimustine
Prednisolamate (prednisolone diethylaminoacetate)
Prednisolone esters
Prednisone
Prednisone esters
Pregnenolone
Pregnenolone acetate
Pregnenolone succinate (pregnenolone hemisuccinate)
Resocortol
Tipredane
Tixocortol
Butixocort (tixocortol butyrate)
Butixocort propionate
Tixocortol pivalate
Methasones and related (16-substituted): 16α-Methyl-11-oxoprednisolone
Alclometasone
Alclometasone dipropionate
Amelometasone
Beclometasone (beclomethasone)
Beclometasone esters
Betamethasone (betametasone)
Betamethasone esters
Cortobenzolone (betamethasone salicylate)
Ciclometasone (ciclomethasone, cyclomethasone)
Clobetasol
Clobetasol propionate
Clobetasone
Clobetasone butyrate
Clocortolone
Clocortolone esters
Cloticasone
Cloticasone propionate
Cormetasone (cormethasone)
Cormetasone acetate
Descinolone
Desoximetasone (desoxymethasone)
Dexamethasone (dexametasone)
Dexamethasone esters
Diflorasone
Diflorasone diacetate
Diflucortolone
Diflucortolone pivalate
Diflucortolone valerate
Dimesone
Dimesone acetate
Doxibetasol (doxybetasol)
Fluclorolone
Flumetasone (flumethasone)
Flumetasone acetate
Flumetasone pivalate
Fluocinolone
Fluocortin
Fluocortin butyl (fluocortin butylate)
Fluocortolone
Fluocortolone esters
Fluprednidene (fluprednylidene)
Fluprednidene acetate
Fluticasone
Fluticasone furoate
Fluticasone propionate
Halocortolone
Halometasone
Icometasone
Icometasone enbutate (icometasone butyrate acetate)
Isoprednidene
Locicortolone (locicortone)
Locicortolone dicibate (locicortone dicibate)
Meclorisone
Meclorisone dibutyrate
Meprednisone (methylprednisone)
Meprednisone acetate
Meprednisone hydrogen succinate (methylprednisone hemisuccinate)
Mometasone
Mometasone furoate
Paramethasone
Paramethasone acetate
Paramethasone disodium phosphate
Paramethasone phosphate
Prednylidene
Prednylidene diethylaminoacetate
Rimexolone
Ticabesone
Ticabesone propionate
Timobesone
Timobesone acetate
Triamcinolone
Triamcinolone diacetate
Ulobetasol (halobetasol)
Ulobetasol propionate
Vamorolone
Cyclic ketals (16,17-cyclized): Acrocinonide (triamcinolone acroleinide)
Amcinafal (triamcinolone pentanonide)
Amcinafide (triamcinolone acetophenide)
Amcinonide (triamcinolone acetate cyclopentanonide)
Budesonide
Ciclesonide
Cicortonide
Deflazacort (azacort)
Descinolone acetonide
Desonide (hydroxyprednisolone acetonide)
Desonide disodium phosphate
Desonide pivalate
Dexbudesonide
Drocinonide
Drocinonide phosphate
Fluazacort
Fluclorolone acetonide (flucloronide)
Fludroxycortide (flurandrenolone, flurandrenolide)
Flumoxonide
Flunisolide
Flunisolide acetate
Fluocinolone acetonide
Ciprocinonide (fluocinolone acetonide cyclopropylcarboxylate)
Fluocinonide (fluocinolide, fluocinolone acetonide acetate)
Procinonide (fluocinolone acetonide propionate)
Formocortal
Halcinonide
Itrocinonide
Rofleponide
Rofleponide palmitate
Tralonide
Triamcinolone acetonide
Flupamesone (triamcinolone acetonide metembonate)
Triamcinolone acetonide esters
Triamcinolone aminobenzal benzamidoisobutyrate (TBI-PAB)
Triclonide
Others/atypical (other expanded steroid ring systems, homosteroids, and non-pregnane steroids): Cortisuzol
Cortivazol
Domoprednate
Naflocort
Nicocortonide
Nicocortonide acetate
Nivacortol (nivazol)
Oxisopred
RU-26988
RU-28362
Non-corticosteroids with some glucocorticoid activity: 15β-Hydroxycyproterone acetate
17α-Hydroxyprogesterone
Bromoketoprogesterone
Chlormadinone acetate
Cyproterone
Cyproterone acetate
Danazol
Delmadinone acetate
Desogestrel
DU-41165
Etonogestrel
Flugestone
Flugestone acetate (flurogestone acetate)
Fluoromedroxyprogesterone acetate
Fluoxymesterone
Gestodene
Medrogestone
Medroxyprogesterone acetate
Megestrol acetate
Metribolone
Norgestomet
Osaterone acetate
Progesterone
Promegestone
RU-2309
Quingestrone
Segesterone acetate (nestorone)
Tetrahydrogestrinone
Nonsteroidal glucocorticoids: AZD-5423
GSK-9027
Mixed(SEGRMs)
Dagrocorat
Fosdagrocorat
Mapracorat
Antagonists
7α-Hydroxy-DHEA
17α-Methylprogesterone
Aglepristone
Asoprisnil
Asoprisnil ecamate
C108297
C113176
CORT-108297
Cyproterone acetate
Dazucorilant
Exicorilant (CORT-125281)
Guggulsterone
Ketoconazole
Lilopristone
LLY-2707
Metapristone (RU-42633)
Miconazole
Mifepristone (RU-486)
Miricorilant (CORT-118335)
Onapristone
ORG-34116
ORG-34517 (SCH-900636)
ORG-34850
Pregnenolone 16α-carbonitrile
Relacorilant (CORT-125134)
RTI 3021–012
RTI 3021–022
Telapristone
Tibolone
Toripristone
Ulipristal acetate
Zavacorilant
Others
Antisense oligonucleotides: IONIS-GCCRRx (ISIS-426115)

See also
Receptor/signaling modulators
Glucocorticoids and antiglucocorticoids
Mineralocorticoid receptor modulators
List of corticosteroids

vteGrowth factor receptor modulatorsAngiopoietin
Agonists: Angiopoietin 1
Angiopoietin 4
Antagonists: Angiopoietin 2
Angiopoietin 3
Kinase inhibitors: Altiratinib
CE-245677
Rebastinib
Antibodies: Evinacumab (against angiopoietin 3)
Nesvacumab (against angiopoietin 2)
CNTF
Agonists: Axokine
CNTF
Dapiclermin
EGF (ErbB)EGF(ErbB1/HER1)
Agonists: Amphiregulin
Betacellulin
EGF (urogastrone)
Epigen
Epiregulin
Heparin-binding EGF-like growth factor (HB-EGF)
Murodermin
Nepidermin
Transforming growth factor alpha (TGFα)
Kinase inhibitors: Afatinib
Agerafenib
Brigatinib
Canertinib
Dacomitinib
Erlotinib
Gefitinib
Grandinin
Icotinib
Lapatinib
Neratinib
Osimertinib
Vandetanib
WHI-P 154
Antibodies: Cetuximab
Depatuxizumab
Depatuxizumab mafodotin
Futuximab
Imgatuzumab
Matuzumab
Necitumumab
Nimotuzumab
Panitumumab
Zalutumumab
ErbB2/HER2
Agonists: Unknown/none
Antibodies: Ertumaxomab
Pertuzumab
Trastuzumab
Trastuzumab deruxtecan
Trastuzumab duocarmazine
Trastuzumab emtansine
Kinase inhibitors: Afatinib
Lapatinib
Mubritinib
Neratinib
Tucatinib
ErbB3/HER3
Agonists: Neuregulins (heregulins) (1, 2, 6 (neuroglycan C))
Antibodies: Duligotumab
Patritumab
Seribantumab
ErbB4/HER4
Agonists: Betacellulin
Epigen
Heparin-binding EGF-like growth factor (HB-EGF)
Neuregulins (heregulins) (1, 2, 3, 4, 5 (tomoregulin, TMEFF))
FGFFGFR1
Agonists: Ersofermin
FGF (1, 2 (bFGF), 3, 4, 5, 6, 8, 10 (KGF2), 20)
Repifermin
Selpercatinib
Trafermin
Velafermin
FGFR2
Agonists: Ersofermin
FGF (1, 2 (bFGF), 3, 4, 5, 6, 7 (KGF), 8, 9, 10 (KGF2), 17, 18, 22)
Palifermin
Repifermin
Selpercatinib
Sprifermin
Trafermin
Antibodies: Aprutumab
Aprutumab ixadotin
Kinase inhibitors: Infigratinib
FGFR3
Agonists: Ersofermin
FGF (1, 2 (bFGF), 4, 8, 9, 18, 23)
Selpercatinib
Sprifermin
Trafermin
Antibodies: Burosumab (against FGF23)
FGFR4
Agonists: Ersofermin
FGF (1, 2 (bFGF), 4, 6, 8, 9, 19)
Trafermin
Unsorted
Agonists: FGF15/19
HGF (c-Met)
Agonists: Fosgonimeton
Hepatocyte growth factor
Potentiators: Dihexa (PNB-0408)
Kinase inhibitors: Altiratinib
AM7
AMG-458
Amuvatinib
BMS-777607
Cabozantinib
Capmatinib
Crizotinib
Foretinib
Golvatinib
INCB28060
JNJ-38877605
K252a
MK-2461
PF-04217903
PF-2341066
PHA-665752
SU-11274
Tivantinib
Volitinib
Antibodies: Emibetuzumab
Ficlatuzumab
Flanvotumab
Onartuzumab
Rilotumumab
Telisotuzumab
Telisotuzumab vedotin
IGFIGF-1
Agonists: des(1-3)IGF-1
Insulin-like growth factor-1 (somatomedin C)
IGF-1 LR3
Insulin-like growth factor-2 (somatomedin A)
Insulin
Mecasermin
Mecasermin rinfabate
Kinase inhibitors: BMS-754807
Linsitinib
NVP-ADW742
NVP-AEW541
OSl-906
Antibodies: AVE-1642
Cixutumumab
Dalotuzumab
Figitumumab
Ganitumab
Robatumumab
R1507
Teprotumumab
Xentuzumab (against IGF-1 and IGF-2)
IGF-2
Agonists: Insulin-like growth factor-2 (somatomedin A)
Antibodies: Dusigitumab
Xentuzumab (against IGF-1 and IGF-2)
Others
Binding proteins: IGFBP (1, 2, 3, 4, 5, 6, 7)
Cleavage products/derivatives with unknown target: Glypromate (GPE, (1-3)IGF-1)
Trofinetide
LNGF (p75NTR)
Agonists: BDNF
BNN-20
BNN-27
Cenegermin
DHEA
DHEA-S
NGF
NT-3
NT-4
Antagonists: ALE-0540
Dexamethasone
EVT-901 (SAR-127963)
Testosterone
Antibodies: Against NGF: ABT-110 (PG110)
ASP-6294
Fasinumab
Frunevetmab
Fulranumab
MEDI-578
Ranevetmab
Tanezumab
Aptamers: Against NGF: RBM-004
Decoy receptors: LEVI-04 (p75NTR-Fc)
PDGF
Agonists: Becaplermin
Platelet-derived growth factor (A, B, C, D)
Kinase inhibitors: Agerafenib
Avapritinib
Axitinib
Crenolanib
Imatinib
Lenvatinib
Masitinib
Motesanib
Nintedanib
Pazopanib
Radotinib
Quizartinib
Ripretinib
Sunitinib
Sorafenib
Toceranib
Antibodies: Olaratumab
Ramucirumab
Tovetumab
RET (GFL)GFRα1
Agonists: Glial cell line-derived neurotrophic factor (GDNF)
Liatermin
Kinase inhibitors: Vandetanib
GFRα2
Agonists: Neurturin (NRTN)
Kinase inhibitors: Vandetanib
GFRα3
Agonists: Artemin (ARTN)
Kinase inhibitors: Vandetanib
GFRα4
Agonists: Persephin (PSPN)
Kinase inhibitors: Vandetanib
Unsorted
Kinase inhibitors: Agerafenib
SCF (c-Kit)
Agonists: Ancestim
Stem cell factor
Kinase inhibitors: Agerafenib
Axitinib
Dasatinib
Imatinib
Masitinib
Nilotinib
Pazopanib
Quizartinib
Sorafenib
Sunitinib
Toceranib
TGFβ
See here instead.
TrkTrkA
Agonists: Amitriptyline
BNN-20
BNN-27
Cenegermin
DHEA
DHEA-S
Gambogic amide
NGF
Tavilermide
Antagonists: ALE-0540
Dexamethasone
FX007
Testosterone
Negative allosteric modulators: VM-902A
Kinase inhibitors: Altiratinib
AZD-6918
CE-245677
CH-7057288
DS-6051
Entrectinib
GZ-389988
K252a
Larotrectinib
Lestaurtinib
Milciclib
ONO-4474
ONO-5390556
PLX-7486
Rebastinib
SNA-120 (pegylated K252a))
Antibodies: Against TrkA: GBR-900; Against NGF: ABT-110 (PG110)
ASP-6294
Fasinumab
Frunevetmab
Fulranumab
MEDI-578
Ranevetmab
Tanezumab
Aptamers: Against NGF: RBM-004
Decoy receptors: ReN-1820 (TrkAd5)
TrkB
Agonists: 3,7-DHF
3,7,8,2'-THF
4'-DMA-7,8-DHF
7,3'-DHF
7,8-DHF
7,8,2'-THF
7,8,3'-THF
Amitriptyline
BDNF
BNN-20
Deoxygedunin
Deprenyl
Diosmetin
DMAQ-B1
HIOC
LM22A-4
N-Acetylserotonin
NT-3
NT-4
Norwogonin (5,7,8-THF)
R7
R13
TDP6
Antagonists: ANA-12
Cyclotraxin B
Gossypetin (3,5,7,8,3',4'-HHF)
Ligands: DHEA
Kinase inhibitors: Altiratinib
AZD-6918
CE-245677
CH-7057288
DS-6051
Entrectinib
GZ-389988
K252a
Larotrectinib
Lestaurtinib
ONO-4474
ONO-5390556
PLX-7486
TrkC
Agonists: BNN-20
DHEA
NT-3
Kinase inhibitors: Altiratinib
AZD-6918
CE-245677
CH-7057288
DS-6051
Entrectinib
GZ-389988
K252a
Larotrectinib
Lestaurtinib
ONO-4474
ONO-5390556
PLX-7486
VEGF
Agonists: Placental growth factor (PGF)
Ripretinib
Telbermin
VEGF (A, B, C, D (FIGF))
Allosteric modulators: Cyclotraxin B
Kinase inhibitors: Agerafenib
Altiratinib
Axitinib
Cabozantinib
Cediranib
Lapatinib
Lenvatinib
Motesanib
Nintedanib
Pazopanib
Pegaptanib
Rebastinib
Regorafenib
Semaxanib
Sorafenib
Sunitinib
Toceranib
Tivozanib
Vandetanib
WHI-P 154
Antibodies: Alacizumab pegol
Bevacizumab
Icrucumab
Ramucirumab
Ranibizumab
Decoy receptors: Aflibercept
Others
Additional growth factors: Adrenomedullin
Colony-stimulating factors (see here instead)
Connective tissue growth factor (CTGF)
Ephrins (A1, A2, A3, A4, A5, B1, B2, B3)
Erythropoietin (see here instead)
Glucose-6-phosphate isomerase (GPI; PGI, PHI, AMF)
Glia maturation factor (GMF)
Hepatoma-derived growth factor (HDGF)
Interleukins/T-cell growth factors (see here instead)
Leukemia inhibitory factor (LIF)
Macrophage-stimulating protein (MSP; HLP, HGFLP)
Midkine (NEGF2)
Migration-stimulating factor (MSF; PRG4)
Oncomodulin
Pituitary adenylate cyclase-activating peptide (PACAP)
Pleiotrophin
Renalase
Thrombopoietin (see here instead)
Wnt signaling proteins
Additional growth factor receptor modulators: Cerebrolysin (neurotrophin mixture)

vteXenobiotic-sensing receptor modulatorsCAR
Agonists: 6,7-Dimethylesculetin
Amiodarone
Artemisinin
Benfuracarb
Carbamazepine
Carvedilol
Chlorpromazine
Chrysin
CITCO
Clotrimazole
Cyclophosphamide
Cypermethrin
DHEA (prasterone)
Efavirenz
Ellagic acid
Griseofulvin
Methoxychlor
Mifepristone
Nefazodone
Nevirapine
Nicardipine
Octicizer
Permethrin
Phenobarbital
Phenytoin
Pregnanedione (5β-dihydroprogesterone)
Reserpine
TCPOBOP
Telmisartan
Tolnaftate
Troglitazone
Valproic acid
Antagonists: 3,17β-Estradiol
3α-Androstanol
3α-Androstenol
3β-Androstanol
17-Androstanol
AITC
Ethinylestradiol
Meclizine
Nigramide J
Okadaic acid
PK-11195
S-07662
T-0901317
PXR
Agonists: 17α-Hydroxypregnenolone
17α-Hydroxyprogesterone
Δ4-Androstenedione
Δ5-Androstenediol
Δ5-Androstenedione
AA-861
Allopregnanediol
Allopregnanedione (5α-dihydroprogesterone)
Allopregnanolone (brexanolone)
Alpha-Lipoic acid
Ambrisentan
AMI-193
Amlodipine besylate
Antimycotics
Artemisinin
Aurothioglucose
Bile acids
Bithionol
Bosentan
Bumecaine
Cafestol
Cephaloridine
Cephradine
Chlorpromazine
Ciglitazone
Clindamycin
Clofenvinfos
Chloroxine
Clotrimazole
Colforsin
Corticosterone
Cyclophosphamide
Cyproterone acetate
Demecolcine
Dexamethasone
DHEA (prasterone)
DHEA-S (prasterone sulfate)
Dibunate sodium
Diclazuril
Dicloxacillin
Dimercaprol
Dinaline
Docetaxel
Docusate calcium
Dodecylbenzenesulfonic acid
Dronabinol
Droxidopa
Eburnamonine
Ecopipam
Enzacamene
Epothilone B
Erythromycin
Famprofazone
Febantel
Felodipine
Fenbendazole
Fentanyl
Flucloxacillin
Fluorometholone
Griseofulvin
Guggulsterone
Haloprogin
Hetacillin potassium
Hyperforin
Hypericum perforatum (St John's wort)
Indinavir sulfate
Lasalocid sodium
Levothyroxine
Linolenic acid
LOE-908
Loratadine
Lovastatin
Meclizine
Metacycline
Methylprednisolone
Metyrapone
Mevastatin
Mifepristone
Nafcillin
Nicardipine
Nicotine
Nifedipine
Nilvadipine
Nisoldipine
Norelgestromin
Omeprazole
Orlistat
Oxatomide
Paclitaxel
Phenobarbital
Piperine
Plicamycin
Prednisolone
Pregnanediol
Pregnanedione (5β-dihydroprogesterone)
Pregnanolone
Pregnenolone
Pregnenolone 16α-carbonitrile
Proadifen
Progesterone
Quingestrone
Reserpine
Reverse triiodothyronine
Rifampicin
Rifaximin
Rimexolone
Riodipine
Ritonavir
Simvastatin
Sirolimus
Spironolactone
Spiroxatrine
SR-12813
Suberoylanilide
Sulfisoxazole
Suramin
Tacrolimus
Tenylidone
Terconazole
Testosterone isocaproate
Tetracycline
Thiamylal sodium
Thiothixene
Thonzonium bromide
Tianeptine
Troglitazone
Troleandomycin
Tropanyl 3,5-dimethulbenzoate
Zafirlukast
Zeranol
Antagonists: Ketoconazole
Sesamin

See also
Receptor/signaling modulators

.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;justify-content:center;align-items:baseline}.mw-parser-output .portal-bar-bordered{padding:0 2em;background-color:#fdfdfd;border:1px solid #a2a9b1;clear:both;margin:1em auto 0}.mw-parser-output .portal-bar-unbordered{padding:0 1.7em;margin-left:0}.mw-parser-output .portal-bar-header{margin:0 1em 0 0.5em;padding:0.2em 0;flex:0 0 auto;min-height:24px;line-height:22px}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0 1 auto;padding:0.15em 0;column-gap:1em}.mw-parser-output .portal-bar-item{display:flex;align-items:baseline;margin:0.15em 0;min-height:24px;text-align:left}.mw-parser-output .portal-bar-logo{width:22px;line-height:22px;margin:0 0.2em;text-align:right}.mw-parser-output .portal-bar-link{margin:0 0.2em;text-align:left}@media screen and (max-width:768px){.mw-parser-output .portal-bar{font-size:88%;font-weight:bold;display:flex;flex-flow:column wrap}.mw-parser-output .portal-bar-header{text-align:center;flex:0;padding-left:0.5em;margin:0 auto}.mw-parser-output .portal-bar-content{display:flex;flex-flow:row wrap;align-items:baseline;flex:0;margin:0 auto;column-gap:1em;border-top:1px solid #a2a9b1}}.mw-parser-output .navbox+link+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .navbox+style+.portal-bar-bordered{margin-top:-1px}.mw-parser-output .portal-bar+.navbox-styles+.navbox{margin-top:-1px}Portals:MedicineVirusesCOVID-19





